PHARMACOGENETICS: A USEFUL TOOL FOR PRECISION MEDICINE
Pharmacogenetics uses the patient’s genetic information to select the most appropriate pharmacological treatment, maximising therapeutic efficacy and minimising adverse effects.
NEUROFARMAGEN® ANALYSES MORE THAN 60 POLYMORPHISMS PRESENT IN 25 GENES RELATED TO PHARMACOKINETICS AND PHARMACODYNAMICS OF THE MOST COMMONLY PRESCRIBED DRUGS IN NEUROPSYCHIATRY
All genetic variants tested are selected according to all available evidence to date, and are routinely reviewed.
NEUROFARMAGEN® IS THE FIRST PHARMACOGENETIC ANALYSIS FOR PSYCHIATRY WITH PROVEN CLINICAL UTILITY
Additional pilot studies show that Neuropharmagen® could also provide benefits in other disorders such as bipolar depression, ADHD or behavioural disorders in adolescents.
IT PROVIDES INFORMATION ON THE RESPONSE TO DRUGS USED IN
✔ Depression
✔ Obsessive-Compulsive Disorder
✔ Schizophrenia
✔ Attention Deficit Hyperactivity Disorder (ADHD)
✔ Anxiety Disorders
✔ Epilepsy
✔ Bipolar Disorder
NEUROFARMAGEN INCLUDES 59 PSYCHOACTIVE DRUGS
It incorporates relevant pharmacogenetic information included in the approved drug labels, as well as recommendations from leading expert groups.
